vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $83.5M, roughly 1.1× BillionToOne, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs 3.2%, a 3.6% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -1.5%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $2.9M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
BLLN vs SCOR — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $93.5M |
| Net Profit | $5.7M | $3.0M |
| Gross Margin | 69.9% | 41.0% |
| Operating Margin | 11.5% | 7.0% |
| Net Margin | 6.8% | 3.2% |
| Revenue YoY | 117.4% | -1.5% |
| Net Profit YoY | 138.3% | -3.7% |
| EPS (diluted) | $0.10 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $93.5M | ||
| Q3 25 | $83.5M | $88.9M | ||
| Q2 25 | — | $89.4M | ||
| Q1 25 | — | $85.7M | ||
| Q4 24 | — | $94.9M | ||
| Q3 24 | $38.4M | $88.5M | ||
| Q2 24 | — | $85.8M | ||
| Q1 24 | — | $86.8M |
| Q4 25 | — | $3.0M | ||
| Q3 25 | $5.7M | $453.0K | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | $-14.9M | $-60.6M | ||
| Q2 24 | — | $-1.7M | ||
| Q1 24 | — | $-1.1M |
| Q4 25 | — | 41.0% | ||
| Q3 25 | 69.9% | 40.6% | ||
| Q2 25 | — | 40.6% | ||
| Q1 25 | — | 39.6% | ||
| Q4 24 | — | 42.4% | ||
| Q3 24 | 52.6% | 41.2% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | — | 42.3% |
| Q4 25 | — | 7.0% | ||
| Q3 25 | 11.5% | 1.9% | ||
| Q2 25 | — | -1.9% | ||
| Q1 25 | — | -2.4% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | -32.9% | -67.4% | ||
| Q2 24 | — | -2.2% | ||
| Q1 24 | — | -2.2% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | 6.8% | 0.5% | ||
| Q2 25 | — | -10.6% | ||
| Q1 25 | — | -4.7% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | -38.8% | -68.5% | ||
| Q2 24 | — | -2.0% | ||
| Q1 24 | — | -1.2% |
| Q4 25 | — | $9.50 | ||
| Q3 25 | $0.10 | $-0.86 | ||
| Q2 25 | — | $-2.73 | ||
| Q1 25 | — | $-1.66 | ||
| Q4 24 | — | $-0.47 | ||
| Q3 24 | $-1.47 | $-12.79 | ||
| Q2 24 | — | $-1.19 | ||
| Q1 24 | — | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $23.6M |
| Total DebtLower is stronger | $55.0M | $41.5M |
| Stockholders' EquityBook value | $-239.5M | $111.4M |
| Total Assets | $327.5M | $407.7M |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $23.6M | ||
| Q3 25 | $195.2M | $26.7M | ||
| Q2 25 | — | $26.0M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $29.9M | ||
| Q3 24 | — | $20.0M | ||
| Q2 24 | — | $14.7M | ||
| Q1 24 | — | $18.7M |
| Q4 25 | — | $41.5M | ||
| Q3 25 | $55.0M | $41.4M | ||
| Q2 25 | — | $41.3M | ||
| Q1 25 | — | $41.3M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $111.4M | ||
| Q3 25 | $-239.5M | $-26.3M | ||
| Q2 25 | — | $-21.7M | ||
| Q1 25 | — | $-13.5M | ||
| Q4 24 | — | $-8.3M | ||
| Q3 24 | $-242.9M | $-2.7M | ||
| Q2 24 | — | $45.8M | ||
| Q1 24 | — | $51.4M |
| Q4 25 | — | $407.7M | ||
| Q3 25 | $327.5M | $406.9M | ||
| Q2 25 | — | $415.9M | ||
| Q1 25 | — | $421.5M | ||
| Q4 24 | — | $430.2M | ||
| Q3 24 | — | $412.5M | ||
| Q2 24 | — | $474.1M | ||
| Q1 24 | — | $477.7M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $3.2M |
| Free Cash FlowOCF − Capex | $6.5M | $2.9M |
| FCF MarginFCF / Revenue | 7.7% | 3.1% |
| Capex IntensityCapex / Revenue | 8.8% | 0.3% |
| Cash ConversionOCF / Net Profit | 2.42× | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | — | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.2M | ||
| Q3 25 | $13.8M | $9.5M | ||
| Q2 25 | — | $932.0K | ||
| Q1 25 | — | $9.1M | ||
| Q4 24 | — | $-10.0M | ||
| Q3 24 | — | $12.5M | ||
| Q2 24 | — | $8.7M | ||
| Q1 24 | — | $6.9M |
| Q4 25 | — | $2.9M | ||
| Q3 25 | $6.5M | $9.4M | ||
| Q2 25 | — | $787.0K | ||
| Q1 25 | — | $8.7M | ||
| Q4 24 | — | $-10.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | — | 3.1% | ||
| Q3 25 | 7.7% | 10.5% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 10.1% | ||
| Q4 24 | — | -10.8% | ||
| Q3 24 | — | 14.0% | ||
| Q2 24 | — | 10.0% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 8.8% | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 1.07× | ||
| Q3 25 | 2.42× | 20.96× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
